CELC — Celcuity LLC

Founder-Led

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Celcuity LLC

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolisib, which selectively targets various Class I isoforms of phosphatidylinositol-3-kinase (PI3K) and the two mechanistic targets of rapamycin (mTOR) sub-complexes, mTORC1 and mTORC2 to treat patients with hormone receptor positive (… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$138.23
Market Cap$6.82B
Float26.8M
Shares Outstanding48.8M
vs. Analyst Target+22.3% to analyst PT
Dividend RateNone
Analyst Target Price$169.00 (7 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$9.5M -$385,591 -$9.2M
2021 N/A -$29.6M -$303,235 -$28.0M
2022 N/A -$40.4M -$210,918 -$39.2M
2023 N/A -$63.8M -$142,772 -$58.3M
2024 N/A -$112M -$129,947 -$101M
2025 $154,000 -$177M -$167,000 -$160M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 N/A -$45.3M
Sep 2025 $154,000 -$43.8M
Dec 2025 N/A -$51.0M
Mar 2026 N/A -$52.8M

Ownership & Float

Insider Ownership10.0%
Institutional Ownership101.2%
Short Float33.3%
% of All Funds Holding3.14%
Number of Funds Holding258

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$121.79Near-term / short-term trend
Weekly40-Week SMA$95.07Medium-term trend
Weekly80-Week SMA$54.70Cyclical trend (business cycle)
Weekly200-Week SMA$29.53Secular trend (multi-year)
Monthly10-Month SMA$97.35Near-term monthly trend
Monthly20-Month SMA$56.03Medium-term monthly trend
Monthly40-Month SMA$34.82Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$77.00 support 1.04x 5 months ago
$50.00 support 2.28x 6 months ago
$38.50 support 2.07x 8 months ago
$13.60 support 5.07x 9 months ago

Historical Earnings Reactions (36 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.49% 0.00% 41.67% 13.00% -6.57%
1 Day -0.37% -0.84% 44.44% 18.94% -10.28%
1 Week 0.29% -0.25% 47.22% 53.79% -18.79%
2 Weeks 1.91% -1.27% 40.00% 68.24% -25.36%
1 Month 2.39% -2.58% 45.71% 90.00% -29.28%

Next earnings: August 13, 2026 (78 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan0.2%44.4%9
Feb-2.8%55.6%9
Mar-0.2%44.4%9
Apr7.2%66.7%9
May6.7%50.0%8
Jun9.9%75.0%8
Jul18.0%25.0%8
Aug1.6%62.5%8
Sep-1.2%37.5%8
Oct12.6%55.6%9
Nov7.1%44.4%9
Dec2.8%33.3%9

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.65% 47.5% 408
Tuesday -0.15% 49.8% 448
Wednesday -0.07% 46.4% 444
Thursday 0.31% 50.1% 437
Friday 0.46% 50.9% 438

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 101.2%

Insider Transactions — Smart Summary

Total insider ownership: 10.0%

Founder-led management: Brian Sullivan (Co-Founder, Chairman & CEO), Lance Laing (Co-Founder, Chief Science Officer, VP, Secretary & Director)

12-Month Insider Activity Summary

Total Filings10
Net Value+N/A
Net Shares Change-225
% of Float-0.0%
C-Suite Filings0
Clusters Detected0

Key Insiders

NameTitleNet ValueFilingsActivity
Dalvey David -$12.2M 4 N/A
BAKER BROS. ADVISORS LP +$9.6M 1 1 buy
Buller Richard E -$2.2M 5 3 sell

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-09-10 BAKER BROS. ADVISORS LP +$9.6M Transaction at $56.27, now +145.7%
2026-05-06 Dalvey David -$3.5M Transaction at $140.68, now -1.7%
2025-12-09 Buller Richard E -$300,569.7 Transaction at $55.59, now +148.6%
2025-12-03 Buller Richard E -$91,635.39 Transaction at $56.48, now +144.7%
2025-11-21 Buller Richard E -$319,417.8 Transaction at $55.78, now +147.8%
2026-01-29 Dalvey David -$2.4M Transaction at $120.03, now +15.2%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Celcuity LLC (CELC) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for CELC on Trend Edge →